18.12.2019 19:00:00
|
IMCD completes the acquisition of South Korean based Whawon Pharm Co. Ltd.
ROTTERDAM, The Netherlands (December 18, 2019) – IMCD N.V. ("IMCD” or "Company”), a leading distributor of speciality chemicals and food ingredients, today announces that it has successfully completed the acquisition of pharmaceutical ingredient distributor Whawon Pharm Co. Ltd. ("Whawon”).
IMCD acquired 57% of the total share capital from the existing Whawon management, who will continue to lead the company. The remaining 43%, will be maintained by the management, for a period up to 5 years after closing.
Attachment

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu IMCD N.V.mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu IMCD N.V.mehr Analysen
Aktien in diesem Artikel
IMCD N.V. | 144,80 | -1,09% |
|